SCHEMBL7879697

SCHEMBL7879697

CN(C(=N)N)C(=O)c1cc2ccc(Oc3ccnc(N)c3)cc2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ROCK2 O75116 2/20 0.39
ROCK1 Q13464 1/20 0.39
SYK P43405 6/20 0.38
FLT3 P36888 3/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
CA2 P00918 2/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
MAPK14 Q16539 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7885067 0.88 KMT2A (0.43) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7884818 0.87 MEN1 (0.41) MEN1KMT2ARXFP1ROCK2SYK
SCHEMBL7884349 0.86 KMT2A (0.43) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7873591 0.86 KMT2A (0.45) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7873782 0.85 MEN1 (0.38) MEN1KMT2ARXFP1ROCK2SYK
SCHEMBL7877937 0.84 MAPK14 (0.37) FLT3HRH4MAPK14NOS3NOS1
SCHEMBL7881777 0.84 KMT2A (0.41) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7882065 0.84 KMT2A (0.53) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7877882 0.83 KMT2A (0.45) MEN1KMT2ARXFP1ROCK2ROCK1
SCHEMBL7873266 0.82 MEN1 (0.45) MEN1KMT2ARXFP1SYKFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed